Ozempic and Wegovy belong to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists, which have become widely popular in recent years
When a decision is to be made on whether someone should get started on [medication] or not, so I feel like this [study] will be very helpful concerning those discussions. We are building evidence that hopefully can be built into prediction models to help patients estimate, based on their individual circumstances, what is the most likely range of weight reduction given their persistence, BMI, sex, medication they are about to start at the time of decision-making on which GLP-1 medication to choose, or whether to choose pharmacotherapy or another modality for the treatment of obesity, Gasoyan said
Esse artigo te ajudou
[DOI] [PMC free article] [PubMed] [Google Scholar] 20.Lin A., Ding Y., Li Z., Jiang A., Liu Z., Wong H.Z.H., Cheng Q., Zhang J., Luo P
Some clinical uses may include specialized methods for managing obesity where the main therapeutic goals are to lose as much fat as possible and improve liver health
This advanced formula delivers CoQ10 and l-carnitine fumarate to assist tissues with high energy demands, particularly the heart, while promoting healthy oxygen utilization and metabolic function
